Analysis Article • Jul 14
Have your own idea? Try our Stock Screener
U.K. (FTSE) Clinical Research and Equipment Industry Analysis
UpdatedJul 21, 2026
DataAggregated Company Financials
Companies7
- 7D-5.0%
- 3M-13.2%
- 1Y-34.6%
- YTDn/a
Over the last 7 days, the Clinical Research and Equipment industry has dropped 6.1%, driven by a pullback from Oxford Nanopore Technologies of 5.2%. On the other hand Oxford BioDynamics is actually up 30%. The industry has fallen 22% in the last year. Earnings are forecast to grow by 52% annually.
Industry Valuation and Performance
Has the U.K. Clinical Research and Equipment Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Tue, 21 Jul 2026 | UK£1.3b | UK£323.1m | -UK£164,731,254.00 | 1156.6x | -7.7x | 3.9x |
| Thu, 18 Jun 2026 | UK£1.4b | UK£323.0m | -UK£166,018,254.00 | 1248.2x | -8.2x | 4.2x |
| Sat, 16 May 2026 | UK£1.4b | UK£318.2m | -UK£167,469,254.00 | n/a | -8.4x | 4.4x |
| Mon, 13 Apr 2026 | UK£1.3b | UK£323.0m | -UK£156,192,254.00 | 9.7x | -8.1x | 3.9x |
| Wed, 11 Mar 2026 | UK£1.4b | UK£324.0m | -UK£161,423,254.00 | 10.9x | -8.7x | 4.3x |
| Fri, 06 Feb 2026 | UK£1.7b | UK£304.6m | -UK£159,441,254.00 | 7.9x | -10.4x | 5.4x |
| Sun, 04 Jan 2026 | UK£1.4b | UK£304.6m | -UK£159,441,254.00 | 8.2x | -9x | 4.7x |
| Tue, 02 Dec 2025 | UK£1.6b | UK£303.9m | -UK£162,910,254.00 | 7.1x | -9.5x | 5.1x |
| Thu, 30 Oct 2025 | UK£1.6b | UK£304.3m | -UK£163,156,254.00 | 8.5x | -9.5x | 5.1x |
| Sat, 27 Sep 2025 | UK£1.7b | UK£304.0m | -UK£163,375,352.00 | 9.9x | -10.2x | 5.5x |
| Mon, 25 Aug 2025 | UK£2.2b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -13.9x | 7.6x |
| Wed, 23 Jul 2025 | UK£2.0b | UK£291.9m | -UK£160,968,352.00 | 6.4x | -12.4x | 6.8x |
| Fri, 20 Jun 2025 | UK£1.5b | UK£319.6m | -UK£190,968,919.60 | 6.6x | -7.9x | 4.7x |
| Sun, 18 May 2025 | UK£1.7b | UK£313.2m | -UK£193,016,833.70 | 11.5x | -8.6x | 5.3x |
| Tue, 15 Apr 2025 | UK£1.6b | UK£315.1m | -UK£185,873,021.35 | 6.3x | -8.8x | 5.2x |
| Thu, 13 Mar 2025 | UK£1.5b | UK£315.5m | -UK£186,115,915.25 | 6.4x | -7.8x | 4.6x |
| Sat, 08 Feb 2025 | UK£1.9b | UK£307.1m | -UK£195,680,087.76 | 6.8x | -9.8x | 6.2x |
| Mon, 06 Jan 2025 | UK£1.9b | UK£307.0m | -UK£195,600,753.84 | 7.4x | -9.7x | 6.2x |
| Wed, 04 Dec 2024 | UK£2.1b | UK£306.5m | -UK£194,903,626.56 | 8.3x | -10.5x | 6.7x |
| Fri, 01 Nov 2024 | UK£2.0b | UK£304.9m | -UK£192,712,985.80 | 10.9x | -10.6x | 6.7x |
| Sun, 29 Sep 2024 | UK£2.2b | UK£303.6m | -UK£191,718,111.40 | 11.1x | -11.4x | 7.2x |
| Tue, 27 Aug 2024 | UK£1.8b | UK£295.6m | -UK£188,241,796.50 | 12.4x | -9.8x | 6.3x |
| Thu, 25 Jul 2024 | UK£1.9b | UK£295.3m | -UK£189,738,047.67 | 12.2x | -9.9x | 6.4x |
| Sat, 22 Jun 2024 | UK£1.5b | UK£296.0m | -UK£190,309,224.21 | 11.5x | -7.7x | 4.9x |
| Mon, 20 May 2024 | UK£1.6b | UK£294.6m | -UK£187,453,754.66 | 8063.9x | -8.7x | 5.6x |
| Wed, 17 Apr 2024 | UK£1.6b | UK£317.8m | -UK£178,616,655.89 | 11.9x | -8.9x | 5x |
| Fri, 15 Mar 2024 | UK£1.9b | UK£295.6m | -UK£212,909,751.31 | 7001.6x | -8.8x | 6.3x |
| Sun, 11 Feb 2024 | UK£2.1b | UK£285.9m | -UK£189,301,187.46 | 7107.4x | -11x | 7.3x |
| Tue, 09 Jan 2024 | UK£3.2b | UK£449.8m | -UK£173,887,936.00 | 62.2x | -18.3x | 7.1x |
| Thu, 07 Dec 2023 | UK£3.1b | UK£452.9m | -UK£170,709,439.00 | 46.7x | -17.9x | 6.7x |
| Sat, 04 Nov 2023 | UK£3.2b | UK£458.1m | -UK£165,180,912.00 | 47.6x | -19.4x | 7x |
| Mon, 02 Oct 2023 | UK£3.0b | UK£448.8m | -UK£169,206,255.00 | 66.1x | -17.9x | 6.7x |
| Wed, 30 Aug 2023 | UK£3.1b | UK£476.4m | -UK£126,736,104.00 | 70.6x | -24.4x | 6.5x |
| Fri, 28 Jul 2023 | UK£3.5b | UK£476.0m | -UK£124,358,582.00 | 69.6x | -27.8x | 7.3x |
Price to Earnings Ratio
-27.8x
Current Industry PE
- Investors are pessimistic on the British Life Sciences Tools and Services industry, indicating that they anticipate long term growth rates will be lower than they have historically.
- The 3-year average PS ratio of 5.8x is higher than the industry's current PS ratio of 4.0x.
Past Earnings Growth
- The earnings for companies in the Life Sciences Tools and Services industry have deteriorated over the last three years.
- Revenues have also declined 12% per year.
- This means overall sales from these companies are declining and losses are subsequently expanding as well.
Industry Comparison
How does U.K. Clinical Research and Equipment compare with similar industries?
| GB Market | 0.26% | |
| Healthcare | -1.81% | |
| Life Sciences | -5.02% | |
| Clinical Research and Equipment | -5.02% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| OBD Oxford BioDynamics | UK£0.0013 | 30.0% +UK£1.3m | -77.0% | PS4.7x | |
| IXI IXICO | UK£0.085 | 3.0% +UK£545.1k | -20.6% | PS2.5x |
